Form EFFECT Whitehawk Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 9, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biocom's 2026 Economic Impact Report Highlights the Strength, Resilience and Future of the Life Science Industry in California
- Associa Chicagoland Hosts Annual Client Appreciation, Associa Cares and Casino Night
- ImPACT Applications, Inc. adds UpRight Science Balance Assessment for Athletes
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share